RetaMaps is not a pharmacy, and we never list, link to, rank or recommend sellers of "research-grade", "RUO" or compounded retatrutide — including products sold under code names.
There is no legitimate retatrutide for sale anywhere. The FDA has stated that retatrutide cannot be used in compounding under federal law, and has issued warning letters to sellers marketing it as a "research" product — see the FDA's page on unapproved GLP-1 drugs. Eli Lilly has sued U.S. sellers and reported thousands of listings.
What that means on RetaMaps:
- Practices whose public materials suggest they sell or administer retatrutide or research peptides are flagged and hidden pending review, and excluded when confirmed.
- Claiming a listing requires attesting that the practice does none of the above.
- Our content never tells readers where to buy any unapproved drug, ever.
The legitimate routes to retatrutide today are clinical trials and Lilly's expanded access program (your physician applies). Read more in our warning on "research peptide" retatrutide.